超早期高血压脑出血微创术治疗的临床研究

目的 :探讨超早期高血压脑出血微创术治疗的疗效和影响疗效的主要因素。方法 :回顾性分析微创术治疗 2 76例高血压脑出血患者的术后疗效。根据发病至手术时间分为超早期组 (≤ 7h)和早期组 ( 8～ 72h)。治疗 3个月后统计分析每组患者的再出血发生率、病死率、致残率及治愈率。结果 :超早期组再出血率 4 .4 1% ,致残率 18.38% ,病死率 19.85 % ,治愈率 5 7.36 % ;早期组再出血率 4 .2 9% ,致残率 36 .4 3% ,病死率 37.14 % ,治愈率 2 2 .14 %。两组比较 ,致残率、病死率及治愈率均有显著差异 (P <0 .0 5 ) ,再出血率无显著差异 (P >0 .0 5 )。结论 :微创术超早期治疗高血压脑出血安全有效 ,病死率低 ,致残率低 ,预后好。

Clinical Study on the Effect of Minimum Invasive Hematoma Evacuation for Patients with Ultra-early Hypertensive Intracerebral Hemorrhage

Objective: To investigate the therapeutic effect of minimum invasive hematoma evacuation in treating patients with ultra early hypertensive intracerebral hemorrhage and the main factors affecting the therapeutic effect. Methods: Therapeutic effects of 276 patients with hypertensive intracerebral hemorrhage received minimum invasive hematoma evacuation were analyzed retrospectively.Patients were divided into two groups based on the period of time from the onset of disease to the operation: ultra early group (<7 h) and early group (8 72 h). The hemorrhage recurring rate, mortality rate, disability rate, and cure rate were statistically analyzed after 3 months' treatment. Results: The hemorrhage recurring rate was 4.41% , disability rate was 18.38% , mortality rate was 19.85% and cure rate was 57.36% in the ultra early group. The hemorrhage recurring rate was 4.29% , disability rate was 36.43% , mortality rate was 37.14% and cure rate was 22.14% in the early group. There was a significant difference in disability rate,mortality rate and cure rate betwen two gruops ( P < 0.05 ), and there was no difference in hemorrhage recurring rate ( P > 0.05 ). Conclusion: Minimum invasive hematoma evacuation is a safe and effective methods in treating patients with ultra early hypertensive intracerebral hemorrhage with low mortality and disability rate and with good prognosis.